Key result
Female patients aged over 60 with ASCVD had a significantly lower risk of acute myocardial infarction (HR 0.67, P<0.001) and other adverse cardiovascular outcomes compared to matched male patients.
Why the study?
Studies evaluating the association between gender and major adverse cardiovascular outcomes in older ASCVD patients had shown inconsistent results.
Does female gender reduce major adverse cardiovascular outcomes in patients aged over 60 years with atherosclerotic cardiovascular disease compared to male gender?
Cohort (n=9,696)
Does female gender reduce major adverse cardiovascular outcomes in patients aged over 60 years with atherosclerotic cardiovascular disease compared to male gender?
Hazard Ratio: 0.67
p-value: p=<0.001
In patients over 60 years old with atherosclerotic cardiovascular disease, female gender is associated with significantly lower rates of acute myocardial infarction, stroke, vascular procedures, and in-hospital mortality compared to male gender.
Gender may influence ASCVD outcomes in elderly patients; this observational analysis leaves open the need for prospective validation.
Atherosclerotic cardiovascular disease (ASCVD) including cerebrovascular disease (CVD), coronary artery disease (CAD), and peripheral arterial disease (PAD), contributes to the major causes of death in the world. Although several studies have evaluated the association between gender and major adverse cardiovascular outcomes in old ASCVD patients, the result is not consistent. Hence, we need a large-scale study to address this issue.This retrospective cohort study included aged over 60 year-old patients with a diagnosis of ASCVD, including CVD, CAD, or PAD, from the database contained in the Taiwan National Health Insurance Bureau during 2001 to 2004. The matched cohort was matched by age, comorbidities, and medical therapies at a 1:1 ratio. A total of 9696 patients were enrolled in this study, that is, there were 4848 and 4848 patients in the matched male and female groups, respectively. The study endpoints included acute myocardial infarction, hemorrhagic stroke, ischemic stroke, vascular procedures, in-hospital mortality, and so on. In multivariate Cox regression analysis in matched cohort, the adjusted hazard ratios (HRs) for female group in predicting acute myocardial infarction, hemorrhagic stroke, ischemic stroke, vascular procedures, and in-hospital mortality were 0.67 (P < .001), 0.73 (P = .0015), 0.78 (P < .001), 0.59 (P < .001), and 0.77 (P = .0007), respectively.In this population-based propensity matched cohort study, age over 60 year-old female patients with ASCVD were associated with lower rates of acute myocardial infarction, hemorrhagic stroke, ischemic stroke, vascular procedures, and in-hospital mortality than male patients. Further prospective studies may be investigated in Taiwan.
No takes yet. Share an insight, caveat, or question.
Lee et al. (2020) conducted a cohort in Atherosclerotic cardiovascular disease (ASCVD) (n=9,696). Female sex vs. Male sex was evaluated on Acute myocardial infarction (HR 0.67, p=<0.001). Female patients aged over 60 with ASCVD had a significantly lower risk of acute myocardial infarction (HR 0.67, P<0.001) and other adverse cardiovascular outcomes compared to matched male patients.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: